Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
This study identified potential AE signals that could aid clinical monitoring and risk identification for tralokinumab. Additionally, close monitoring is warranted for dupilumab-associated injection site reactions and tralokinumab-associated conjunctivitis and keratitis throughout treatment.
Authors
- Xinjuan Sun
- Yang Li
- Yueping Jiang
Institutions
- Gaochun People's Hospital (CN)
- Command Hospital Air Force (IN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.3389/fimmu.2026.1769109
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00